Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Global Call for Collaborators – Pfizer Migraine Research

Pfizer

This competitive call for collaborator(s) (CFC(s)) seeks to identify investigators with innovative research proposals who are interested in partnering with Pfizer and potentially other likeminded investigators on co-developing research studies in migraine. Proposals selected from this CFC(s) will work in collaboration with the Pfizer medical team to co-develop a research project and final study protocol. In all studies, the investigator will be the regulatory sponsor of the study.

• Projects that will be considered for Pfizer support will focus on Migraine.

• The effects of rimegepant on non-pain aspects of migraine (in particular - cognitive dysfunction, mood/affective disturbances, vertigo), or assessing/defining functional clinical benefit in migraine.

• The effects of rimegepant on migraine populations with high disease burden (e.g., chronic migraine, medication overuse/medication overuse headache, psychiatric comorbidities).

• Systematic evaluation of the short- term preventive use of rimegepant during periods of increased risk for migraine.

• The assessment of rimegepant in non-migraine headache disorders (e.g., cluster headache and post-traumatic headache).

• Outcomes associated with the use of rimegepant or zavegepant in understudied adult populations, such as men, underrepresented racial, ethnic, and LGBTQIA+ individuals.

• Combination studies with rimegepant or zavegepant in the acute treatment of migraine.

• The assessment of zavegepant in the following: status migrainosus, cluster headache, functional GI disorders.

Specialties

Neurosciences

Pharmaceuticals

Nursing

Pharmacology

Eligibility Requirements

Applicant Eligibility Criteria

• The institution and Principal Investigator (PI) must be based in one of the eligible countries.

• Only organizations are eligible to receive funds and in-kind support, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).

• If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.

• The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.

• The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).

• The PI must be an employee or contractor of the requesting organization.

• If selected, the PI and their organization are willing and able to engage in a Research Collaboration with Pfizer; see definition of ‘Research Collaboration’ further down for details.

• For all Research Collaborations (RCs), the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the initiative supported by the RC, including compliance with any regulatory requirements. Pfizer may be involved in the design of the study protocol and project development, as well as the conduct or monitoring of the research program. Preference will be given to PIs that are open to collaborative agreements with other institutions with similar research interests.

• Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Funding awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be cancelled.

Sponsor Details

Sponsor Institute/Organizations: Pfizer

Address: Pfizer, New York, United States.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity